The Gross Margin of Rekah Pharmaceutical Industry Ltd (REKA.TA) is 22.36%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 22.36% |
| 2023-12-31 | 24.93% |
| 2022-12-31 | 26.92% |
| 2021-12-31 | 24.69% |
| 2020-12-31 | 25.86% |
| 2019-12-31 | 31.10% |
| 2018-12-31 | 32.35% |
| 2017-12-31 | 33.03% |
| 2016-12-31 | 31.03% |
| 2015-12-31 | 31.73% |